Department of Chemistry, Chemical Biology and Biomedical Engineering, Stevens Institute of Technology, Hoboken 07030, USA.
J Control Release. 2013 Oct 10;171(1):73-80. doi: 10.1016/j.jconrel.2013.06.031. Epub 2013 Jul 2.
We report on hydrogen-bonded layer-by-layer (LbL) films as a robust, reusable platform for temperature-triggered "on-demand" release of drugs. Films with high drug loading capacity, temperature-controlled on-off drug release, and stability at physiological conditions were enabled by assembly of tannic acid (TA) with temperature-responsive block copolymer micelles (BCMs), which were pre-formed by heating solutions of a neutral diblock copolymer, poly(N-vinylpyrrolidone)-b-poly(N-isopropylacrylamide) (PVPON-b-PNIPAM), to a temperature above the lower critical solution temperature (LCST) of PNIPAM. The BCM/TA films exhibited temperature-triggered swelling/deswelling transitions at physiological conditions (swelling ratios of 1.75 and 1.2 at 37°C and 20°C, respectively). A model drug, doxorubicin (DOX) was incorporated into the film at a high drug-to-matrix ratio (9.3wt.% of DOX per film mass), with a total loading capacity controlled by the film thickness. At 37°C, DOX was efficiently retained within the hydrophobic BCM cores of BCM/TA films, whereas exposure to a lower temperature (20°C) triggered fast DOX release. While neither bare BCM-containing films nor films loaded with DOX showed cytotoxicity at 37°C, drug released from films at lower temperature exhibited high potency against breast cancer cells. Repeated on/off drug release was demonstrated with 1.5-μm-thick DOX-loaded films, allowing at least three 30-min cooling cycles with consistent DOX (12-16% of loaded DOX released for each cycle) released over a 4-day period. Despite significant stress associated with multiple swelling/deswelling cycles, films maintained their structural integrity in PBS, and each film could be repeatedly loaded with drug and used more than 15 times with only ~7% loss in film thickness and no obvious changes in reloading capacity or release profiles. This work presents the first proof-of-concept utility of temperature-responsive BCM-containing films for repeated on-demand release of a drug.
我们报告了氢键层层(LbL)膜作为一种稳健、可重复使用的平台,用于温度触发的药物“按需”释放。通过组装单宁酸(TA)与温度响应的嵌段共聚物胶束(BCMs),实现了具有高载药量、温度控制的开/关药物释放以及在生理条件下稳定性的膜,这些胶束是通过加热中性二嵌段共聚物聚(N-乙烯基吡咯烷酮)-b-聚(N-异丙基丙烯酰胺)(PVPON-b-PNIPAM)的溶液至高于 PNIPAM 的低临界溶液温度(LCST)来预先形成的。BCM/TA 膜在生理条件下表现出温度触发的溶胀/收缩转变(在 37°C 和 20°C 时分别为 1.75 和 1.2 的溶胀比)。模型药物阿霉素(DOX)以高药物-基质比(每膜质量中 DOX 的比例约为 9.3wt.%)掺入膜中,总载药量由膜厚度控制。在 37°C 时,DOX 有效地保留在 BCM/TA 膜的疏水 BCM 核内,而暴露于较低温度(20°C)会触发 DOX 的快速释放。在 37°C 时,既没有裸露的 BCM 含膜也没有负载 DOX 的膜表现出细胞毒性,而从较低温度下释放的药物对乳腺癌细胞表现出高效力。使用 1.5μm 厚的负载 DOX 的膜进行了重复的开/关药物释放,允许在 4 天的时间内进行至少三个 30 分钟的冷却循环,每次循环释放约 12-16%的负载 DOX。尽管与多次溶胀/收缩循环相关的压力很大,但在 PBS 中,膜保持其结构完整性,并且每个膜可以重复加载药物并且可以使用超过 15 次,而膜厚度仅损失约 7%,并且再装载能力或释放曲线没有明显变化。这项工作首次证明了温度响应的 BCM 含膜用于重复按需释放药物的概念验证效用。